SPATA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.39900000473148E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.25649999999944E-05 |
Normal-vs-Stage2 |
2.664300E-03 |
Normal-vs-Stage3 |
5.3943960409697E-11 |
Normal-vs-Stage4 |
7.543999980264E-09 |
Stage1-vs-Stage2 |
5.933800E-01 |
Stage1-vs-Stage3 |
1.433510E-04 |
Stage1-vs-Stage4 |
1.383170E-03 |
Stage2-vs-Stage3 |
1.479020E-01 |
Stage2-vs-Stage4 |
2.049600E-01 |
Stage3-vs-Stage4 |
8.073200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.01950000348006E-08 |
Normal-vs-AfricanAmerican |
9.11599995490064E-09 |
Normal-vs-Asian |
9.304000E-01 |
Caucasian-vs-AfricanAmerican |
1.873900E-02 |
Caucasian-vs-Asian |
4.615500E-02 |
AfricanAmerican-vs-Asian |
2.421200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.26109999998292E-07 |
Normal-vs-Female |
6.40059999446052E-08 |
Male-vs-Female |
8.552800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.961700E-04 |
Normal-vs-Age(41-60Yrs) |
7.60740000000926E-05 |
Normal-vs-Age(61-80Yrs) |
4.81739981239571E-10 |
Normal-vs-Age(81-100Yrs) |
2.27409999999928E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.960400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.679200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.968400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.493800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.595800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.832570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.592800E-01 |
Normal-vs-Grade 2 |
7.581900E-04 |
Normal-vs-Grade 3 |
2.49480003322589E-09 |
Normal-vs-Grade 4 |
1.93840055118244E-10 |
Grade 1-vs-Grade 2 |
5.084300E-02 |
Grade 1-vs-Grade 3 |
5.74359999999663E-05 |
Grade 1-vs-Grade 4 |
2.02129999999912E-05 |
Grade 2-vs-Grade 3 |
1.609020E-04 |
Grade 2-vs-Grade 4 |
1.9669199999961E-05 |
Grade 3-vs-Grade 4 |
1.054850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.321100E-03 |
Normal-vs-ccB subtype |
1.08310005408896E-09 |
ccA subtype-vs-ccB subtype |
1.174030E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.08539999998936E-06 |
Normal-vs-N1 |
1.036100E-02 |
N0-vs-N1 |
7.725400E-01 |
|
|